Applied Therapeutics (APLT) Income Statement (2018 - 2025)
Income Statement report data from Mar 31, 2018 to Sep 30, 2025 for Applied Therapeutics (APLT).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||||||||
Total Revenue | 1.00M | - | - | - | 120K (-14.29%) | 140K (-26.32%) | 190K | -670.00K | - | - | 11M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | |||||||||||||||||||||||||||||||
Research And Development | 9.60M (-3.23%) | 9.92M (+26.53%) | 7.84M (-32.99%) | 12M (-21.11%) | 15M (+48.30%) | 10M (-18.17%) | 12M (-20.13%) | 15M (+41.80%) | 11M (-9.18%) | 12M (-25.47%) | 16M (+31.84%) | 12M (-7.85%) | 13M (-14.81%) | 15M (+2.46%) | 15M (-4.39%) | 16M (-10.68%) | 18M (+18.92%) | 15M (+2.42%) | 14M (+4.63%) | 14M (-30.78%) | 20M (-3.90%) | 21M (+185.56%) | 7.27M (-47.20%) | 14M (+84.83%) | 7.45M (+75.29%) | 4.25M (-38.14%) | 6.87M (+28.17%) | 5.36M (+96.34%) | 2.73M (+40.72%) | 1.94M (+33.79%) | 1.45M |
Selling General And Administrative | 8.16M (-38.09%) | 13M (-25.49%) | 18M (-17.07%) | 21M (+41.82%) | 15M (+42.16%) | 11M (+16.65%) | 9.07M (+79.96%) | 5.04M (+7.01%) | 4.71M (-10.96%) | 5.29M (-5.20%) | 5.58M (-18.90%) | 6.88M (+10.26%) | 6.24M (+1.79%) | 6.13M (-24.04%) | 8.07M (-29.15%) | 11M (+5.17%) | 11M (-2.17%) | 11M (+13.54%) | 9.75M (-1.91%) | 9.94M (-0.80%) | 10M (+33.24%) | 7.52M (+44.62%) | 5.20M (+33.33%) | 3.90M (+18.54%) | 3.29M (-21.29%) | 4.18M (+124.73%) | 1.86M (+195.24%) | 630K (+5.00%) | 600K (+50.00%) | 400K (-4.76%) | 420K |
Operating Expenses | 18M (-23.12%) | 23M (-9.52%) | 26M (-22.68%) | 33M (+10.55%) | 30M (+45.14%) | 21M (-3.29%) | 21M (+4.62%) | 20M (+31.23%) | 16M (-9.78%) | 17M (-20.17%) | 22M (+13.44%) | 19M (-2.01%) | 19M (-10.04%) | 22M (-6.84%) | 23M (-14.79%) | 27M (-4.64%) | 28M (+9.85%) | 26M (+6.94%) | 24M (+1.89%) | 24M (-20.75%) | 30M (+5.98%) | 28M (+126.78%) | 12M (-29.43%) | 18M (+64.37%) | 11M (+27.37%) | 8.44M (-3.32%) | 8.73M (+45.74%) | 5.99M (+80.42%) | 3.32M (+41.88%) | 2.34M (+25.13%) | 1.87M |
Operating Income | |||||||||||||||||||||||||||||||
Operating Income | -16.76M (-27.45%) | -23.10M (-9.48%) | -25.52M (-22.71%) | -33.02M (+11.03%) | -29.74M (+45.50%) | -20.44M (-3.08%) | -21.09M (+0.38%) | -21.01M (+35.64%) | -15.49M (-9.84%) | -17.18M (+58.20%) | -10.86M (-42.75%) | -18.97M (-2.01%) | -19.36M (-10.04%) | -21.52M (-6.84%) | -23.10M (-14.79%) | -27.11M (-4.64%) | -28.43M (+9.90%) | -25.87M (+6.90%) | -24.20M (+1.89%) | -23.75M (-20.73%) | -29.96M (+5.94%) | -28.28M (+126.78%) | -12.47M (-29.43%) | -17.67M (+64.37%) | -10.75M (+27.37%) | -8.44M (-3.32%) | -8.73M (+45.74%) | -5.99M (+80.42%) | -3.32M (+41.88%) | -2.34M (+25.13%) | -1.87M |
Ebit | -16.76M (-27.45%) | -23.10M (-9.48%) | -25.52M (-22.71%) | -33.02M (+11.03%) | -29.74M (+45.50%) | -20.44M (-3.08%) | -21.09M (+0.38%) | -21.01M (+35.64%) | -15.49M (-9.84%) | -17.18M (+58.20%) | -10.86M (-42.75%) | -18.97M (-2.01%) | -19.36M (-10.04%) | -21.52M (-6.84%) | -23.10M (-14.79%) | -27.11M (-4.64%) | -28.43M (+9.90%) | -25.87M (+6.90%) | -24.20M (+1.89%) | -23.75M (-20.73%) | -29.96M (+5.94%) | -28.28M (+126.78%) | -12.47M (-29.43%) | -17.67M (+64.37%) | -10.75M (+27.37%) | -8.44M (-3.32%) | -8.73M (+45.74%) | -5.99M (+80.42%) | -3.32M (+41.88%) | -2.34M (+25.13%) | -1.87M |
EBITDA | -18.99M (-10.97%) | -21.33M (-2.25%) | -21.82M | 44M | -68.59M | 2.90M | -83.94M (+122.77%) | -37.68M (-11.07%) | -42.37M (+43.24%) | -29.58M (+191.72%) | -10.14M (-29.73%) | -14.43M (-24.45%) | -19.10M (-26.14%) | -25.86M (+11.85%) | -23.12M (-14.87%) | -27.16M (-4.43%) | -28.42M (+10.03%) | -25.83M (+6.82%) | -24.18M (+2.07%) | -23.69M (-20.61%) | -29.84M (+6.34%) | -28.06M (+126.84%) | -12.37M (-29.84%) | -17.63M (+64.61%) | -10.71M (+26.90%) | -8.44M (-3.32%) | -8.73M (+29.91%) | -6.72M (+57.01%) | -4.28M (+34.59%) | -3.18M (+36.48%) | -2.33M |
Other Income / Expenses | |||||||||||||||||||||||||||||||
Other Non Operating Income | -10.00K (-66.67%) | -30.00K (+50.00%) | -20.00K (-75.00%) | -80.00K (+300.00%) | -20.00K (-33.33%) | -30.00K (0.00%) | -30.00K (0.00%) | -30.00K | 10K | - | 30K | -180.00K (+1700.00%) | -10.00K (-88.89%) | -90.00K (-10.00%) | -100.00K (-80.77%) | -520.00K (+766.67%) | -60.00K (-50.00%) | -120.00K (+100.00%) | -60.00K (+20.00%) | -50.00K (+400.00%) | -10.00K | 40K | -20.00K (0.00%) | -20.00K | 30K | - | - | -1.14M (+18.75%) | -960.00K (+12.94%) | -850.00K (+80.85%) | -470.00K |
Net Income | |||||||||||||||||||||||||||||||
Net Income From Continuing Operations | -18.99M (-10.97%) | -21.33M (-2.25%) | -21.82M | 44M | -68.59M | 2.90M | -83.94M (+122.77%) | -37.68M (-11.07%) | -42.37M (+43.24%) | -29.58M (+191.72%) | -10.14M (-29.73%) | -14.43M (-24.45%) | -19.10M (-26.14%) | -25.86M (+11.85%) | -23.12M (-14.87%) | -27.16M (-4.43%) | -28.42M (+10.03%) | -25.83M (+6.82%) | -24.18M (+2.07%) | -23.69M (-20.61%) | -29.84M (+6.34%) | -28.06M (+126.84%) | -12.37M (-29.84%) | -17.63M (+64.61%) | -10.71M (+26.90%) | -8.44M (-3.32%) | -8.73M (+29.91%) | -6.72M (+57.01%) | -4.28M (+34.59%) | -3.18M (+36.48%) | -2.33M |
Net Income | -18.99M (-10.97%) | -21.33M (-2.25%) | -21.82M | 44M | -68.59M | 2.90M | -83.94M (+122.77%) | -37.68M (-11.07%) | -42.37M (+43.24%) | -29.58M (+191.72%) | -10.14M (-29.73%) | -14.43M (-24.45%) | -19.10M (-26.14%) | -25.86M (+11.85%) | -23.12M (-14.87%) | -27.16M (-4.43%) | -28.42M (+10.03%) | -25.83M (+6.82%) | -24.18M (+2.07%) | -23.69M (-20.61%) | -29.84M (+6.34%) | -28.06M (+126.84%) | -12.37M (-29.84%) | -17.63M (+64.61%) | -10.71M (+26.90%) | -8.44M (-3.32%) | -8.73M (+29.91%) | -6.72M (+57.01%) | -4.28M (+34.59%) | -3.18M (+36.48%) | -2.33M |
Comprehensive Income Net Of Tax | - | - | - | -105.62M (+53.99%) | -68.59M | 2.90M | -83.94M (-29.94%) | -119.81M (+182.77%) | -42.37M (+43.24%) | -29.58M (+190.28%) | -10.19M (-87.63%) | -82.35M (+331.60%) | -19.08M (-25.96%) | -25.77M (+11.61%) | -23.09M (-78.13%) | -105.58M (+270.59%) | -28.49M (+10.17%) | -25.86M (+6.77%) | -24.22M (-74.25%) | -94.07M (+214.51%) | -29.91M (+6.14%) | -28.18M (+129.48%) | -12.28M (-73.02%) | -45.51M (+325.33%) | -10.70M (+26.78%) | -8.44M (-3.32%) | -8.73M (-47.15%) | -16.52M (+285.98%) | -4.28M | - | - |